Stay updated on GEMINI 2 Tolebrutinib in RMS Clinical Trial
Sign up to get notified when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.

Latest updates to the GEMINI 2 Tolebrutinib in RMS Clinical Trial page
- Check2 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a software/build update for the page. This change does not alter the study content or public-facing information.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe study’s location listing for “Gūrgaon, India” was normalized to “Gurgaon, India” for two entries, likely correcting diacritic formatting. The page also reflects an update to the site/page “Revision” version.SummaryDifference0.1%

- Check31 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded two location entries: Gūrgaon, India, 122001 and Gūrgaon, India, 122002. Removed Gurgaon, India, 122001 and Gurgaon, India, 122002.SummaryDifference0.0%

- Check59 days agoChange DetectedAdded Gurgaon, India, 122001 and Gurgaon, India, 122002 as new study locations. Updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check67 days agoChange DetectedThe Indian site entries 122001 and 122002 changed from Gurgaon to Gūrgaon (diacritic included); this is a spelling/diacritic update to the same locations.SummaryDifference0.1%

Stay in the know with updates to GEMINI 2 Tolebrutinib in RMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.